Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays

• US 4,480,042 A
• Filed: 05/18/1983
• Issued: 10/30/1984
• Est. Priority Date: 10/28/1981
• Status: Expired due to Term

• Current Assignee: Dade Behring, Inc. (Siemens AG)
• Original Assignee: E. I. du Pont de Nemours and Company (Corteva, Inc.)
• Inventors: Craig, Alan R., Luddy, Michael A. G., Looney, Catharine E., Frey, William A., Leflar, Charles C.
• Primary Examiner(s): Turk, Arnold
• Application Number:
  US06/495,621
• Time in Patent Office: 531 Days
• Field of Search: 436/533, 436/500, 436/805, 436/815
• US Class Current: 436/533
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/815 Test for named compound or class of compounds

Abstract

Novel particle reagents for light scattering immunoassays are provided. The particle reagents are high refractive index shell-core polymers covalently bonded to compounds of biological interest or analogs thereof. A method of measuring unknown concentrations of these compounds of biological interest by measuring changes in turbidity caused by particle agglutination or its inhibition is also provided.

Claims

1. A method for measuring compounds of biological interest comprising the steps of

(A) incubating

(1) a particle reagent having high refractive index consisting essentially of:

(a) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(i) an ethylenically unsaturated monomer having a functional group capable of reacting with a compound of biological interest selected from the group consisting of epoxy, carboxyl, amino, hydroxyl and aldehyde,

(ii) optionally, other ethylenically unsaturated monomers in an amount sufficient to produce water insoluble polymer particles, and

(iii) not more than 10 parts by weight of the outer shell of the monomers of the inner core, said outer shell being formed by polymerization in the presence of said inner core and wherein said polymer particles has approximate diameter range of 0.03-0.1 μ

m;

and is covalently attached to

(b) an analog of a compound of biological interest;

(2) a liquid suspected of containing the compound of biological interest; and

(3) an agglutinating agent; and

(B) photometrically measuring increased particle size resulting from agglutination.

2. The method of claim 1 wherein during the incubation step (A) there is also present an agglutinating accelerator.

3. The method of claim 2 wherein the agglutinating accelerator is selected from the group consisting of polyethylene glycol and sodium dodecyl sulfate.